These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 12795077)

  • 1. [Pure red cell aplasia developed during treatment with erythropoietin. Complete remission during immunosuppressive therapy].
    Høi-Hansen T; Lauritzen AM; Hansen PB
    Ugeskr Laeger; 2003 May; 165(19):2001-2. PubMed ID: 12795077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-mediated pure red cell aplasia due to epoetin alfa during antiviral therapy of chronic hepatitis C.
    Stravitz RT; Chung H; Sterling RK; Luketic VA; Sanyal AJ; Price AS; Purrington A; Shiffman ML
    Am J Gastroenterol; 2005 Jun; 100(6):1415-9. PubMed ID: 15929778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on reintroduction of epoetin in a patient with pure red call aplasia.
    Campbell N; Krishnakumar S; Matijevic A; Almond M
    Nephrol Dial Transplant; 2008 Oct; 23(10):3365. PubMed ID: 18567693
    [No Abstract]   [Full Text] [Related]  

  • 4. Re-challenging patients who developed pure red cell aplasia with epoetin: can it be done?
    Macdougall IC; Roche A; Rossert J; Casadevall N; Francois P; Kemeny DM
    Nephrol Dial Transplant; 2004 Nov; 19(11):2901-5. PubMed ID: 15496566
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pure red blood cell aplasia associated with neutralizing antibodies against erythropoietin induced by epoetin alfa:a new form of acquired erythroblastopenia in auremic patients].
    Cases A; Esforzado N; Mas M; Ricart MJ; Cruzado JM
    Nefrologia; 2003; 23(3):266-70. PubMed ID: 12891943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoietin-induced, antibody-mediated pure red cell aplasia.
    Rossert J;
    Eur J Clin Invest; 2005 Dec; 35 Suppl 3():95-9. PubMed ID: 16281965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pure red-cell aplasia and epoetin therapy.
    Bennett CL; Luminari S; Nissenson AR; Tallman MS; Klinge SA; McWilliams N; McKoy JM; Kim B; Lyons EA; Trifilio SM; Raisch DW; Evens AM; Kuzel TM; Schumock GT; Belknap SM; Locatelli F; Rossert J; Casadevall N
    N Engl J Med; 2004 Sep; 351(14):1403-8. PubMed ID: 15459301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pure red cell aplasia induced by erythropoiesis-stimulating agents.
    Pollock C; Johnson DW; Hörl WH; Rossert J; Casadevall N; Schellekens H; Delage R; De Francisco A; Macdougall I; Thorpe R; Toffelmire E
    Clin J Am Soc Nephrol; 2008 Jan; 3(1):193-9. PubMed ID: 18178785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin.
    Casadevall N; Nataf J; Viron B; Kolta A; Kiladjian JJ; Martin-Dupont P; Michaud P; Papo T; Ugo V; Teyssandier I; Varet B; Mayeux P
    N Engl J Med; 2002 Feb; 346(7):469-75. PubMed ID: 11844847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eprex-associated pure red cell aplasia and leachates.
    Schellekens H; Jiskoot W
    Nat Biotechnol; 2006 Jun; 24(6):613-4. PubMed ID: 16763579
    [No Abstract]   [Full Text] [Related]  

  • 11. Epoetin-induced pure red cell aplasia: diagnosis and treatment.
    Macdougall IC
    Curr Opin Nephrol Hypertens; 2007 Nov; 16(6):585-8. PubMed ID: 18089975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epoetin alfa (Eprex): reports of pure red blood cell aplasia.
    Wooltorton E
    CMAJ; 2002 Feb; 166(4):480. PubMed ID: 11873930
    [No Abstract]   [Full Text] [Related]  

  • 13. Two haemodialysis patients with epoetin alfa-induced pure red-cell aplasia recovered despite treatment with another epoetin preparation.
    Vartia A; Asola MR; Tertti R; Kunelius P; Metsärinne KP
    Nephrol Dial Transplant; 2004 May; 19(5):1313-6. PubMed ID: 15102972
    [No Abstract]   [Full Text] [Related]  

  • 14. Response to cyclosporine A in a patient with pure red cell aplasia due to antierythropoietin-alpha antibodies.
    Fraer M; Campbell A; Sawaya BP
    Semin Dial; 2006; 19(3):251-4. PubMed ID: 16689978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pure red cell aplasia as a complication of treatment with recombinant human erythropoietin].
    Grzegorzewska AE; Sucharzewska-Tomczak M
    Pol Merkur Lekarski; 2004 Oct; 17(100):407-9. PubMed ID: 15690716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pure red-cell aplasia and recombinant erythropoietin.
    Gershon SK; Luksenburg H; Coté TR; Braun MM
    N Engl J Med; 2002 May; 346(20):1584-6; author reply 1584-6. PubMed ID: 12015400
    [No Abstract]   [Full Text] [Related]  

  • 17. Recommendations on haematological criteria for the diagnosis of epoetin-induced pure red cell aplasia.
    Casadevall N; Cournoyer D; Marsh J; Messner H; Pallister C; Parker-Williams J; Rossert J
    Eur J Haematol; 2004 Dec; 73(6):389-96. PubMed ID: 15522059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful resumption of epoetin alfa after rituximab treatment in a patient with pure red cell aplasia.
    Mandreoli M; Finelli C; Lopez A; Ascani S; Vianelli N; Baccarani M; Santoro A
    Am J Kidney Dis; 2004 Oct; 44(4):757-61. PubMed ID: 15384028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pure red-cell aplasia secondary to antierythropoietin antibodies.
    Guest SS; Levitt L
    N Engl J Med; 2003 Dec; 349(26):2572-3. PubMed ID: 14695426
    [No Abstract]   [Full Text] [Related]  

  • 20. Recovery from anti-recombinant-human-erythropoietin associated pure red cell aplasia in end-stage renal disease patients after renal transplantation.
    Praditpornsilpa K; Buranasot S; Bhokaisuwan N; Avihingsanon Y; Pisitkul T; Kansanabuch T; Eiam-Ong S; Chusil S; Intarakumtornchai T; Tungsanga K
    Nephrol Dial Transplant; 2005 Mar; 20(3):626-30. PubMed ID: 15735244
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.